Showing results (171-180 of 183) with videos related to
Sort By:
Pageof 19
Journal of the American College of Cardiology|March 19, 2013
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Michael J Ackerman, et al.The Journal of Biological Chemistry|April 1, 2015
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2Hannah Nguyen, Abdellah Allali-Hassani, Stephen Antonysamy, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2005
The development of potent and selective bisarylmaleimide GSK3 inhibitorsThomas A Engler, Sushant Malhotra, Timothy P Burkholder, et al.Journal of Medicinal Chemistry|April 2, 2005
Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacyAlfonso de Dios, Chuan Shih, Beatriz López de Uralde, et al.The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.Journal of Medicinal Chemistry|February 16, 2021
A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6Yudao Shen, Fengling Li, Magdalena M Szewczyk, et al.Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.Bioorganic & Medicinal Chemistry Letters|November 28, 2007
Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38alpha MAP kinase inhibitors with excellent in vivo antiinflammatory propertiesMary Mader, Alfonso de Dios, Chuan Shih, et al.Pageof 19